Connect Biopharma Holdings (CNTB) Earnings Date & Reports
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD)... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CNTB is expected to report earnings to fall 6.01% to -172 cents per share on November 18
Q3'26
Est.
$-1.72
Q2'26
Beat
by $0.33
Q1'26
Missed
by $2.07
Q4'25
Beat
by $1.84
Q3'25
Beat
by $1.80
The last earnings report on August 13 showed earnings per share of -183 cents, beating the estimate of -216 cents. With 645.85K shares outstanding, the current market capitalization sits at 68.01M.